Genetic and epigenetic aberrations of CDKN2A lead to enhanced carcinogenesis and poor prognosis in various cancer types including lymphoma, skin cancer, ovarian cancer, and prostate cancer.19 The gene discussed is CDKN2A; the disease is Familial prostate cancer.